Taken together, we have highlighted GLP-1 as a novel therapeutic marker for identifying and treating the neuropathology of depression
GLP-1s: If fat loss is part of what's drawing you to CJC-1295, you may want to consider its more popular sister peptides, GLP-1s (semaglutide, tirzepatide, and the soon-to-be-approved retatrutide)
Diet and nutrition create the foundation that tirzepatide builds upon
In contrast, exendin-4 decreased S6K activity in the VMH of lean rats re-fed for four hours [83] (Figure 5)
This requires starting the evaluation process over but often solves the problem
(We can access food and other dopamine-producing things at the press of a button.) Still, our brains are wired to be preoccupied with finding food and, when we do, to find it rewarding